A Canadian parliamentary committee will review draft legislation Thursday that could pave the way for Canada to sell generic drugs to fight HIV/AIDS, tuberculosis and malaria to developing countries.
Microsoft blasted the E.U.'s €497.2 million antitrust ruling, claiming it would infringe its intellectual property rights.
Alston & Bird has added eight patent, trademark, and copyright attorneys to its New York office from Coudert Brothers, including the head of Coudert’s worldwide IP practice.
Zoran Corp. and its subsidiary Oak Technology have filed a lawsuit against MediaTek and Mintek, accusing the Taiwanese rivals of infringing patents for drive controllers and DVD/CD controllers and chips.
A sweeping policy reform aimed at standardizing regulatory data protection for drugs is now in effect across the European Union.
Zoran Corp. and its subsidiary Oak Technology have filed a complaint with the U.S. International Trade Commission against MediaTek Inc., alleging that the Taiwanese rival’s DVD player and optical disk controller chips and chipsets infringe three patents co-owned by Zoran and Oak.
Satellite television broadcaster EchoStar and Gemstar-TV Guide International settled their four-year litigation over patents for on-screen program guides, signing a deal under which Echostar will pay Gemstar $190 million to use its technology and brand.
Gemstar-TV Guide International Inc. and Pioneer settled their patent litigation and signed a cross-licensing agreement, the companies said.
In another sign that India is moving toward data protection for drug patents, the government has formed a high-level panel to explore whether the country should legislate a ban on unfair use of data furnished to regulators.
The Court of Appeals for the Federal Circuit has vacated a lower court's ruling in Gemstar-TV Guide and SuperGuide's lawsuit against satellite broadcaster EchoStar Communications over patents for on-screen program guides.
Canada’s federal government has reintroduced to Parliament proposed changes to drug and patent laws that will make it easier for developing countries to obtain cheaper generic drugs.
International law firm Shaw Pittman has hired Steven E. Adkins, a seasoned patent attorney with broad experience at the International Trade Commission, as a partner in its litigation and intellectual property practice.
China’s top battery maker and rival Energizer Holdings have signed a cross-licensing agreement, ending a dispute at the U.S. International Trade Commission.
Sughrue Mion, PLLC, one of the largest intellectual property boutiques in the U.S., elected six of its attorneys to the partnership, the firm said Monday.
Seasoned international trade and intellectual property attorney Charles Schill has joined national law firm Steptoe & Johnson LLP's Washington office as a partner.
Once again, Brazil's government is playing hardball in its efforts to get deep discounts on anti-HIV drugs.
Wockhardt becomes the first domestic Indian drug maker to secure an exclusive marketing right as the government grants an EMR for its topical anti-bacterial drug Nadoxin.
India’s government introduced its patent bill ahead of schedule, seeking to bring the country into compliance with its international obligations regarding intellectual property rights by 2005.
Indian drug companies are lobbying the government for an exemption from patent infringement provisions in amendments to the country’s patent law for drugs already in the market.
Government approves introduction of bills aimed at securing TRIPS compliance and stiffen penalties for drug counterfeiting.